Cargando…

KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition

Detalles Bibliográficos
Autores principales: Rouleau, E, Spyratos, F, Dieumegard, B, Guinebretière, J M, Lidereau, R, Bièche, I
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607232/
https://www.ncbi.nlm.nih.gov/pubmed/19078954
http://dx.doi.org/10.1038/sj.bjc.6604815
_version_ 1782163034460913664
author Rouleau, E
Spyratos, F
Dieumegard, B
Guinebretière, J M
Lidereau, R
Bièche, I
author_facet Rouleau, E
Spyratos, F
Dieumegard, B
Guinebretière, J M
Lidereau, R
Bièche, I
author_sort Rouleau, E
collection PubMed
description
format Text
id pubmed-2607232
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-26072322009-12-09 KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition Rouleau, E Spyratos, F Dieumegard, B Guinebretière, J M Lidereau, R Bièche, I Br J Cancer Letter to the Editor Nature Publishing Group 2008-12-09 2008-12-09 /pmc/articles/PMC2607232/ /pubmed/19078954 http://dx.doi.org/10.1038/sj.bjc.6604815 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Rouleau, E
Spyratos, F
Dieumegard, B
Guinebretière, J M
Lidereau, R
Bièche, I
KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition
title KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition
title_full KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition
title_fullStr KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition
title_full_unstemmed KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition
title_short KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition
title_sort kras mutation status in colorectal cancer to predict response to egfr targeted therapies: the need for a more precise definition
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607232/
https://www.ncbi.nlm.nih.gov/pubmed/19078954
http://dx.doi.org/10.1038/sj.bjc.6604815
work_keys_str_mv AT rouleaue krasmutationstatusincolorectalcancertopredictresponsetoegfrtargetedtherapiestheneedforamoreprecisedefinition
AT spyratosf krasmutationstatusincolorectalcancertopredictresponsetoegfrtargetedtherapiestheneedforamoreprecisedefinition
AT dieumegardb krasmutationstatusincolorectalcancertopredictresponsetoegfrtargetedtherapiestheneedforamoreprecisedefinition
AT guinebretierejm krasmutationstatusincolorectalcancertopredictresponsetoegfrtargetedtherapiestheneedforamoreprecisedefinition
AT lidereaur krasmutationstatusincolorectalcancertopredictresponsetoegfrtargetedtherapiestheneedforamoreprecisedefinition
AT biechei krasmutationstatusincolorectalcancertopredictresponsetoegfrtargetedtherapiestheneedforamoreprecisedefinition